Home Healthcare IT Neurodegenerative Disease Market Size, Share & Growth Report by 2034

Neurodegenerative Disease Market Size & Outlook, 2026-2034

Neurodegenerative Disease Market Size, Share & Trends Analysis Report By Disease Indication (Multiple Sclerosis, Parkinson's Disease, Alzheimer's Disease, Others), By Drug Type (Immunomodulator, Vesicular Monoamine Transporter 2 (VMAT2), Others), By Routes of Administration (Oral, Intravenous (IV) delivery, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Report Code: SRHI1582DR
Last Updated : Dec, 2025
Pages : 110
Author : Debashree Bora
Format : PDF, Excel

Market Segmentation

  1. Neurodegenerative Disease Market, By Disease Indication (2022-2034)
    1. Multiple Sclerosis
    2. Parkinson's Disease
    3. Alzheimer's Disease
    4. Others
  2. Neurodegenerative Disease Market, By Drug Type (2022-2034)
    1. Immunomodulator
    2. Vesicular Monoamine Transporter 2 (VMAT2)
    3. Others
  3. Neurodegenerative Disease Market, By Routes of Administration (2022-2034)
    1. Oral
    2. Intravenous (IV) delivery
    3. Others
    1. North America
      1. North America Neurodegenerative Disease Market, By Disease Indication
        1. Multiple Sclerosis
          1. Parkinson's Disease
            1. Alzheimer's Disease
              1. Others
              2. North America Neurodegenerative Disease Market, By Drug Type
                1. Immunomodulator
                  1. Vesicular Monoamine Transporter 2 (VMAT2)
                    1. Others
                    2. North America Neurodegenerative Disease Market, By Routes of Administration
                      1. Oral
                        1. Intravenous (IV) delivery
                          1. Others
                          2. U.S.
                            1. U.S. Neurodegenerative Disease Market, By Disease Indication
                              1. Multiple Sclerosis
                                1. Parkinson's Disease
                                  1. Alzheimer's Disease
                                    1. Others
                                    2. U.S. Neurodegenerative Disease Market, By Drug Type
                                      1. Immunomodulator
                                        1. Vesicular Monoamine Transporter 2 (VMAT2)
                                          1. Others
                                          2. U.S. Neurodegenerative Disease Market, By Routes of Administration
                                            1. Oral
                                              1. Intravenous (IV) delivery
                                                1. Others
                                              2. Canada
                                            2. Europe
                                              1. Europe Neurodegenerative Disease Market, By Disease Indication
                                                1. Multiple Sclerosis
                                                  1. Parkinson's Disease
                                                    1. Alzheimer's Disease
                                                      1. Others
                                                      2. Europe Neurodegenerative Disease Market, By Drug Type
                                                        1. Immunomodulator
                                                          1. Vesicular Monoamine Transporter 2 (VMAT2)
                                                            1. Others
                                                            2. Europe Neurodegenerative Disease Market, By Routes of Administration
                                                              1. Oral
                                                                1. Intravenous (IV) delivery
                                                                  1. Others
                                                                  2. U.K.
                                                                    1. U.K. Neurodegenerative Disease Market, By Disease Indication
                                                                      1. Multiple Sclerosis
                                                                        1. Parkinson's Disease
                                                                          1. Alzheimer's Disease
                                                                            1. Others
                                                                            2. U.K. Neurodegenerative Disease Market, By Drug Type
                                                                              1. Immunomodulator
                                                                                1. Vesicular Monoamine Transporter 2 (VMAT2)
                                                                                  1. Others
                                                                                  2. U.K. Neurodegenerative Disease Market, By Routes of Administration
                                                                                    1. Oral
                                                                                      1. Intravenous (IV) delivery
                                                                                        1. Others
                                                                                      2. Germany
                                                                                      3. France
                                                                                      4. Spain
                                                                                      5. Italy
                                                                                      6. Russia
                                                                                      7. Nordic
                                                                                      8. Benelux
                                                                                      9. Rest of Europe
                                                                                    2. APAC
                                                                                      1. APAC Neurodegenerative Disease Market, By Disease Indication
                                                                                        1. Multiple Sclerosis
                                                                                          1. Parkinson's Disease
                                                                                            1. Alzheimer's Disease
                                                                                              1. Others
                                                                                              2. APAC Neurodegenerative Disease Market, By Drug Type
                                                                                                1. Immunomodulator
                                                                                                  1. Vesicular Monoamine Transporter 2 (VMAT2)
                                                                                                    1. Others
                                                                                                    2. APAC Neurodegenerative Disease Market, By Routes of Administration
                                                                                                      1. Oral
                                                                                                        1. Intravenous (IV) delivery
                                                                                                          1. Others
                                                                                                          2. China
                                                                                                            1. China Neurodegenerative Disease Market, By Disease Indication
                                                                                                              1. Multiple Sclerosis
                                                                                                                1. Parkinson's Disease
                                                                                                                  1. Alzheimer's Disease
                                                                                                                    1. Others
                                                                                                                    2. China Neurodegenerative Disease Market, By Drug Type
                                                                                                                      1. Immunomodulator
                                                                                                                        1. Vesicular Monoamine Transporter 2 (VMAT2)
                                                                                                                          1. Others
                                                                                                                          2. China Neurodegenerative Disease Market, By Routes of Administration
                                                                                                                            1. Oral
                                                                                                                              1. Intravenous (IV) delivery
                                                                                                                                1. Others
                                                                                                                              2. Korea
                                                                                                                              3. Japan
                                                                                                                              4. India
                                                                                                                              5. Australia
                                                                                                                              6. Taiwan
                                                                                                                              7. South East Asia
                                                                                                                              8. Rest of Asia-Pacific
                                                                                                                            2. Middle East and Africa
                                                                                                                              1. Middle East and Africa Neurodegenerative Disease Market, By Disease Indication
                                                                                                                                1. Multiple Sclerosis
                                                                                                                                  1. Parkinson's Disease
                                                                                                                                    1. Alzheimer's Disease
                                                                                                                                      1. Others
                                                                                                                                      2. Middle East and Africa Neurodegenerative Disease Market, By Drug Type
                                                                                                                                        1. Immunomodulator
                                                                                                                                          1. Vesicular Monoamine Transporter 2 (VMAT2)
                                                                                                                                            1. Others
                                                                                                                                            2. Middle East and Africa Neurodegenerative Disease Market, By Routes of Administration
                                                                                                                                              1. Oral
                                                                                                                                                1. Intravenous (IV) delivery
                                                                                                                                                  1. Others
                                                                                                                                                  2. UAE
                                                                                                                                                    1. UAE Neurodegenerative Disease Market, By Disease Indication
                                                                                                                                                      1. Multiple Sclerosis
                                                                                                                                                        1. Parkinson's Disease
                                                                                                                                                          1. Alzheimer's Disease
                                                                                                                                                            1. Others
                                                                                                                                                            2. UAE Neurodegenerative Disease Market, By Drug Type
                                                                                                                                                              1. Immunomodulator
                                                                                                                                                                1. Vesicular Monoamine Transporter 2 (VMAT2)
                                                                                                                                                                  1. Others
                                                                                                                                                                  2. UAE Neurodegenerative Disease Market, By Routes of Administration
                                                                                                                                                                    1. Oral
                                                                                                                                                                      1. Intravenous (IV) delivery
                                                                                                                                                                        1. Others
                                                                                                                                                                      2. Turkey
                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                      4. South Africa
                                                                                                                                                                      5. Egypt
                                                                                                                                                                      6. Nigeria
                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                    2. LATAM
                                                                                                                                                                      1. LATAM Neurodegenerative Disease Market, By Disease Indication
                                                                                                                                                                        1. Multiple Sclerosis
                                                                                                                                                                          1. Parkinson's Disease
                                                                                                                                                                            1. Alzheimer's Disease
                                                                                                                                                                              1. Others
                                                                                                                                                                              2. LATAM Neurodegenerative Disease Market, By Drug Type
                                                                                                                                                                                1. Immunomodulator
                                                                                                                                                                                  1. Vesicular Monoamine Transporter 2 (VMAT2)
                                                                                                                                                                                    1. Others
                                                                                                                                                                                    2. LATAM Neurodegenerative Disease Market, By Routes of Administration
                                                                                                                                                                                      1. Oral
                                                                                                                                                                                        1. Intravenous (IV) delivery
                                                                                                                                                                                          1. Others
                                                                                                                                                                                          2. Brazil
                                                                                                                                                                                            1. Brazil Neurodegenerative Disease Market, By Disease Indication
                                                                                                                                                                                              1. Multiple Sclerosis
                                                                                                                                                                                                1. Parkinson's Disease
                                                                                                                                                                                                  1. Alzheimer's Disease
                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                    2. Brazil Neurodegenerative Disease Market, By Drug Type
                                                                                                                                                                                                      1. Immunomodulator
                                                                                                                                                                                                        1. Vesicular Monoamine Transporter 2 (VMAT2)
                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                          2. Brazil Neurodegenerative Disease Market, By Routes of Administration
                                                                                                                                                                                                            1. Oral
                                                                                                                                                                                                              1. Intravenous (IV) delivery
                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                              2. Mexico
                                                                                                                                                                                                              3. Argentina
                                                                                                                                                                                                              4. Chile
                                                                                                                                                                                                              5. Colombia
                                                                                                                                                                                                              6. Rest of LATAM

                                                                                                                                                                                                          Available for purchase with detailed segment data, forecasts, and regional insights.

                                                                                                                                                                                                          Get This Report

                                                                                                                                                                                                          Download Free Sample

                                                                                                                                                                                                          Note: Please ensure you provide an active email address as we will be sending sample details via email.
                                                                                                                                                                                                          The button will be active once the above form is filled

                                                                                                                                                                                                          Our Clients:

                                                                                                                                                                                                          LG Electronics
                                                                                                                                                                                                          AMCAD Engineering
                                                                                                                                                                                                          KOBE STEEL LTD.
                                                                                                                                                                                                          Hindustan National Glass & Industries Limited
                                                                                                                                                                                                          Voith Group
                                                                                                                                                                                                          International Paper
                                                                                                                                                                                                          Hansol Paper
                                                                                                                                                                                                          Whirlpool Corporation
                                                                                                                                                                                                          Sony
                                                                                                                                                                                                          Samsung Electronics
                                                                                                                                                                                                          Qualcomm
                                                                                                                                                                                                          Google
                                                                                                                                                                                                          Fiserv
                                                                                                                                                                                                          Veto-Pharma
                                                                                                                                                                                                          Nippon Becton Dickinson
                                                                                                                                                                                                          Merck
                                                                                                                                                                                                          Argon Medical Devices
                                                                                                                                                                                                          Abbott
                                                                                                                                                                                                          Ajinomoto
                                                                                                                                                                                                          Denon
                                                                                                                                                                                                          Doosan
                                                                                                                                                                                                          Meiji Seika Kaisha Ltd
                                                                                                                                                                                                          LG Chemicals
                                                                                                                                                                                                          LCY chemical group
                                                                                                                                                                                                          Bayer
                                                                                                                                                                                                          Airrane
                                                                                                                                                                                                          BASF
                                                                                                                                                                                                          Toyota Industries
                                                                                                                                                                                                          Nissan Motors
                                                                                                                                                                                                          Neenah
                                                                                                                                                                                                          Mitsubishi
                                                                                                                                                                                                          Hyundai Motor Company

                                                                                                                                                                                                          We are featured on :

                                                                                                                                                                                                          WhatsApp
                                                                                                                                                                                                          Chat with us on WhatsApp
                                                                                                                                                                                                          Address:
                                                                                                                                                                                                          Office 515 A, Amanora Chambers,
                                                                                                                                                                                                          Amanora Park Town, Hadapsar,
                                                                                                                                                                                                          Pune 411028, Maharashtra, India.
                                                                                                                                                                                                          Contact Us:
                                                                                                                                                                                                          +1 646 905 0080 (U.S.)
                                                                                                                                                                                                          +91 8087085354 (India)
                                                                                                                                                                                                          +44 203 695 0070 (U.K.)

                                                                                                                                                                                                          sales@straitsresearch.com

                                                                                                                                                                                                          Quick Links
                                                                                                                                                                                                          Help
                                                                                                                                                                                                          Verified. Protected. Secure.
                                                                                                                                                                                                          DMCA.com Protection Status
                                                                                                                                                                                                          Secure Payments:
                                                                                                                                                                                                          Follow Us:
                                                                                                                                                                                                          www.straitsresearch.com © Copyright . All rights Reserved.